The Board of Abbott India at its meeting held on 07 November 2024 has approved the appointment of Sridhar Kadangode (DIN: 06715478) as an Additional Director of the Company with effect from 07 November 2024. Powered by Capital Market - Live News

Net profit of Abbott India rose 14.59% to Rs 358.61 crore in the quarter ended September 2024 as against Rs 312.94 crore during the previous quarter ended September 2023. Sales rose 9.27% to Rs 1632.67 crore in the quarter ended September 2024 as against Rs 1494.14 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales1632.671494.14 9 OPM %26.8925.49 - PBDT496.94433.26 15 PBT479.43415.42 15 NP358.61312.94 15 Powered by Capital Market - Live News

Abbott India will hold a meeting of the Board of Directors of the Company on 7 November 2024Powered by Capital Market - Live News

Abbott India announced the resignation of Ashok Saini as Commercial Director - GenNext, Vaccines and Neurolife of the Company, effective close of business hours of 16 October 2024. Powered by Capital Market - Live News

Net profit of Abbott India rose 13.01% to Rs 328.01 crore in the quarter ended June 2024 as against Rs 290.24 crore during the previous quarter ended June 2023. Sales rose 5.32% to Rs 1557.61 crore in the quarter ended June 2024 as against Rs 1479.00 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales1557.611479.00 5 OPM %25.1024.00 - PBDT455.59407.66 12 PBT437.22390.49 12 NP328.01290.24 13 Powered by Capital Market - Live News